Autophagic/lysosomal dysfunction in Alzheimer's disease

Alzheimer's Research and Therapy

Volumn 5, Issue 5, 2013, Pages

  Orr, Miranda E ^a   Oddo, Salvatore ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYSTATIN; PRESENILIN;

ALZHEIMER DISEASE; AUTOPHAGY; AUTOSOMAL DOMINANT INHERITANCE; GENE MUTATION; HUMAN; LYSOSOME; LYSOSOME STORAGE DISEASE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; REVIEW;

EID: 84887909793     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt217     Document Type: Review

References (69)

1. Alzheimer's disease. Querfurth HW, LaFerla FM, N Engl J Med 2010 362 329 344 10.1056/NEJMra0909142 20107219
2. Intracellular amyloid-beta in Alzheimer's disease. LaFerla FM, Green KN, Oddo S, Nat Rev Neurosci 2007 8 499 509 10.1038/nrn2168 17551515 (Pubitemid 46985362)
3. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA, Am J Pathol 2000 157 277 286 10.1016/S0002-9440(10)64538-5 10880397 (Pubitemid 30641743)
4. Autophagy in human health and disease. Choi AM, Ryter SW, Levine B, N Engl J Med 2013 368 651 662 10.1056/NEJMra1205406 23406030
5. Autophagy: many paths to the same end. Cuervo AM, Mol Cell Biochem 2004 263 55 72 15524167 (Pubitemid 39256145)
6. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH, Mol Biol Cell 2009 20 1992 2003 10.1091/mbc.E08-12-1249 19225151
7. Autophagy as a regulated pathway of cellular degradation. Klionsky DJ, Emr SD, Science 2000 290 1717 1721 11099404 (Pubitemid 32004796)
8. Autophagosome formation: tracing the source. Bernard A, Klionsky DJ, Dev Cell 2013 25 116 117 10.1016/j.devcel.2013.04.004 23639440
9. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. Platt FM, Boland B, van der Spoel AC, J Cell Biol 2012 199 723 734 10.1083/jcb.201208152 23185029
10. Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology. Cataldo AM, Peterhoff CM, Schmidt SD, Terio NB, Duff K, Beard M, Mathews PM, Nixon RA, J Neuropathol Exp Neurol 2004 63 821 830 15330337 (Pubitemid 39038504)
11. Inhibition of glycogen synthase kinase-3 ameliorates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies. Avrahami L, Farfara D, Shaham-Kol M, Vassar R, Frenkel D, Eldar-Finkelman H, J Biol Chem 2013 288 1295 1306 10.1074/jbc.M112.409250 23155049
12. Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease. Ko DC, Milenkovic L, Beier SM, Manuel H, Buchanan J, Scott MP, PLoS Genet 2005 1 81 95 10.1371/journal.pgen.0010081 16103921
13. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y, Histol Histopathol 1997 12 25 31 9046040 (Pubitemid 27106916)
14. Neuronal autophagy in experimental Creutzfeldt-Jakob's disease. Boellaard JW, Schlote W, Tateishi J, Acta Neuropathol 1989 78 410 418 10.1007/BF00688178 2675530 (Pubitemid 19200591)
15. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y, Mol Biol Cell 2004 15 1101 1111 14699058 (Pubitemid 38316219)
16. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM, J Neuropathol Exp Neurol 2005 64 113 122 15751225 (Pubitemid 40349309)
17. Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, Jiang Y, Duff K, Uchiyama Y, Näslund J, Mathews PM, Cataldo AM, Nixon RA, J Cell Biol 2005 171 87 98 10.1083/jcb.200505082 16203860 (Pubitemid 41434604)
18. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N, Nature 2006 441 885 889 10.1038/nature04724 16625204
19. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K, Nature 2006 441 880 884 10.1038/nature04723 16625205
20. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, J Neurosci 2008 28 6926 6937 10.1523/JNEUROSCI. 0800-08.2008 18596167
21. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T, J Clin Invest 2008 118 2190 2199 18497889 (Pubitemid 351872337)
22. The Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond. Funderburk SF, Wang QJ, Yue Z, Trends Cell Biol 2010 20 355 362 10.1016/j.tcb.2010.03.002 20356743
23. Beclin 1 complex in autophagy and Alzheimer disease. Jaeger PA, Wyss-Coray T, Arch Neurol 2010 67 1181 1184 10.1001/archneurol.2010.258 20937944
24. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C, Yankner BA, Scherzer CR, Yuan J, Proc Natl Acad Sci U S A 2010 107 14164 14169 10.1073/pnas.1009485107 20660724
25. Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. Ginsberg SD, Mufson EJ, Counts SE, Wuu J, Alldred MJ, Nixon RA, Che S, J Alzheimers Dis 2010 22 631 639 20847427
26. The very many faces of presenilins and the gamma-secretase complex. Smolarkiewicz M, Skrzypczak T, Wojtaszek P, Protoplasma 2013 Mar 16. [Epub ahead of print]
27. Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. Supnet C, Bezprozvanny I, Cell Calcium 2011 50 303 309 10.1016/j.ceca.2011.05.013 21663966
28. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. Coen K, Flannagan RS, Baron S, Carraro-Lacroix LR, Wang D, Vermeire W, Michiels C, Munck S, Baert V, Sugita S, Wuytack F, Hiesinger PR, Grinstein S, Annaert W, J Cell Biol 2012 198 23 35 10.1083/jcb.201201076 22753898
29. Presenilin is necessary for efficient proteolysis through the autophagy-lysosome system in a gamma-secretase-independent manner. Neely KM, Green KN, LaFerla FM, J Neurosci 2011 31 2781 2791 10.1523/JNEUROSCI.5156-10. 2010 21414900
30. Presenilin-null cells have altered two-pore calcium channel expression and lysosomal calcium: implications for lysosomal function. Neely Kayala KM, Dickinson GD, Minassian A, Walls KC, Green KN, Laferla FM, Brain Res 2012 1489 8 16 23103503
31. Purified TPC isoforms form NAADP receptors with distinct roles for Ca(2+) signaling and endolysosomal trafficking. Ruas M, Rietdorf K, Arredouani A, Davis LC, Lloyd-Evans E, Koegel H, Funnell TM, Morgan AJ, Ward JA, Watanabe K, Cheng X, Churchill GC, Zhu MX, Platt FM, Wessel GM, Parrington J, Galione A, Curr Biol 2010 20 703 709 10.1016/j.cub.2010.02.049 20346675
32. Nicotinic acid adenine dinucleotide phosphate (NAADP) regulates autophagy in cultured astrocytes. Pereira GJ, Hirata H, Fimia GM, do Carmo LG, Bincoletto C, Han SW, Stilhano RS, Ureshino RP, Bloor-Young D, Churchill G, Piacentini M, Patel S, Smaili SS, J Biol Chem 2011 286 27875 27881 10.1074/jbc.C110.216580 21610076
33. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA, Cell 2010 141 1146 1158 10.1016/j.cell.2010.05.008 20541250
34. Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Wolfe DM, Lee JH, Kumar A, Lee S, Orenstein SJ, Nixon RA, Eur J Neurosci 2013 37 1949 1961 10.1111/ejn.12169 23773064
35. On the role of v-ATPase V0a1-dependent degradation in Alzheimer disease. Williamson WR, Hiesinger PR, Commun Integr Biol 2010 3 604 607 10.4161/cib.3.6.13364 21331254
36. A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. Zhang X, Garbett K, Veeraraghavalu K, Wilburn B, Gilmore R, Mirnics K, Sisodia SS, J Neurosci 2012 32 8633 8648 10.1523/JNEUROSCI.0556-12.2012 22723704
37. Proteases in autophagy. Kaminskyy V, Zhivotovsky B, Biochim Biophys Acta 2012 1824 44 50 10.1016/j.bbapap.2011.05.013 21640203
38. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, Bronson RT, Olsen BR, Proc Natl Acad Sci USA 2002 99 7883 7888 10.1073/pnas.112632299 12048238 (Pubitemid 34650974)
39. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L, Neuron 2006 51 703 714 10.1016/j.neuron.2006.07.027 16982417 (Pubitemid 44374903)
40. Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein. Wang C, Sun B, Zhou Y, Grubb A, Gan L, J Biol Chem 2012 287 39834 39841 10.1074/jbc.M112.371641 23024364
41. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson D, Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM, Yang AJ, Wilson DA, St George-Hyslop P, Westaway D, Mathews PM, Levy E, Cuervo AM, Nixon RA, Brain 2011 134 258 277 10.1093/brain/awq341 21186265
42. Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases. Gruninger-Leitch F, Schlatter D, Kung E, Nelbock P, Dobeli H, J Biol Chem 2002 277 4687 4693 10.1074/jbc.M109266200 11741910 (Pubitemid 34968499)
43. Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. Hook VY, Kindy M, Hook G, J Biol Chem 2008 283 7745 7753 10.1074/jbc.M708362200 18184658
44. Trace proteins in biological fluids. IV. Physicochemical properties and sites of formation of gamma-trace and beta-trace proteins. Hochwald GM, Pepe AJ, Thorbecke GJ, Proc Soc Exp Biol Med 1967 124 961 966 10.3181/00379727-124-31897 4164643
45. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Crawford FC, Freeman MJ, Schinka JA, Abdullah LI, Gold M, Hartman R, Krivian K, Morris MD, Richards D, Duara R, Anand R, Mullan MJ, Neurology 2000 55 763 768 10.1212/WNL.55.6.763 10993992
46. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM, Arch Neurol 2000 57 1579 1583 10.1001/archneur.57.11.1579 11074789
47. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW, Am J Pathol 2001 159 1061 1068 10.1016/S0002-9440(10)61781-6 11549598 (Pubitemid 32847196)
48. Cystatin C modulates cerebral beta-amyloidosis. Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufenbiel M, Levy E, Grubb A, Jucker M, Nat Genet 2007 39 1437 1439 10.1038/ng.2007.23 18026102 (Pubitemid 350191342)
49. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E, Nat Genet 2007 39 1440 1442 10.1038/ng.2007.29 18026100 (Pubitemid 350191347)
50. Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. Tizon B, Sahoo S, Yu H, Gauthier S, Kumar AR, Mohan P, Figliola M, Pawlik M, Grubb A, Uchiyama Y, Bandyopadhyay U, Cuervo AM, Nixon RA, Levy E, PLoS One 2010 5 9819 10.1371/journal.pone.0009819 20352108
51. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-beta precursor protein. Parr C, Carzaniga R, Gentleman SM, Van Leuven F, Walter J, Sastre M, Mol Cell Biol 2012 32 4410 4418 10.1128/MCB.00930-12 22927642
52. The role of mTOR signaling in Alzheimer disease. Oddo S, Front Biosci (Schol Ed) 2012 4 941 952 22202101
53. TOR signaling in growth and metabolism. Wullschleger S, Loewith R, Hall MN, Cell 2006 124 471 484 10.1016/j.cell.2006.01.016 16469695 (Pubitemid 43199434)
54. Dual suppressive effect of MTORC1 on autophagy: tame the dragon by shackling both the head and the tail. Zhou J, Tan SH, Codogno P, Shen HM, Autophagy 2013 9 803 805 10.4161/auto.23965 23439250
55. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. Zhou J, Tan SH, Nicolas V, Bauvy C, Yang ND, Zhang J, Xue Y, Codogno P, Shen HM, Cell Res 2013 23 508 523 10.1038/cr.2013.11 23337583
56. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini DM, Ballabio A, EMBO J 2012 31 1095 1108 10.1038/emboj.2012.32 22343943
57. Autophagy and aging. Rubinsztein DC, Marino G, Kroemer G, Cell 2011 146 682 695 10.1016/j.cell.2011.07.030 21884931
58. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. Caccamo A, Majumder S, Richardson A, Strong R, Oddo S, J Biol Chem 2010 285 13107 13120 10.1074/jbc.M110.100420 20178983
59. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM, Neuron 2003 39 409 421 10.1016/S0896-6273(03)00434-3 12895417 (Pubitemid 36937044)
60. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V, PLoS One 2010 5 9979 10.1371/journal.pone.0009979 20376313
61. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ, Oddo S, Aging Cell 2013 12 370 380 10.1111/acel.12057 23425014
62. Beclin-1-interacting autophagy protein Atg14L targets the SNARE-associated protein Snapin to coordinate endocytic trafficking. Kim HJ, Zhong Q, Sheng ZH, Yoshimori T, Liang C, Jung JU, J Cell Sci 2012 125 4740 4750 10.1242/jcs.100339 22797916
63. The Atg6/Vps30/Beclin 1 ortholog BEC-1 mediates endocytic retrograde transport in addition to autophagy in C. elegans. Ruck A, Attonito J, Garces KT, Núnez L, Palmisano NJ, Rubel Z, Bai Z, Nguyen KC, Sun L, Grant BD, Hall DH, Meléndez A, Autophagy 2011 7 386 400 10.4161/auto.7.4.14391 21183797
64. Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. Majumder S, Richardson A, Strong R, Oddo S, PLoS One 2011 6 25416 10.1371/journal.pone.0025416 21980451
65. Rapamycin promotes beta-amyloid production via ADAM-10 inhibition. Zhang S, Salemi J, Hou H, Zhu Y, Mori T, Giunta B, Obregon D, Tan J, Biochem Biophys Res Commun 2010 398 337 341 10.1016/j.bbrc.2010.06.017 20542014
66. Pathogenic lysosomal depletion in Parkinson's disease. Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P, Vila M, J Neurosci 2010 30 12535 12544 10.1523/JNEUROSCI.1920-10.2010 20844148
67. Neuronal autophagy and neurodegenerative diseases. Son JH, Shim JH, Kim KH, Ha JY, Han JY, Exp Mol Med 2012 44 89 98 10.3858/emm.2012.44.2.031 22257884
68. Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy. Ching JK, Weihl CC, Autophagy 2013 9 799 800 10.4161/auto.23958 23439279
69. Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten. Raben N, Wong A, Ralston E, Myerowitz R, Am J Med Genet C Semin Med Genet 2012 160 13 21